Physician profile
Sara A Lander
NPI 1275648826
$6,781.23
in general payments reported to CMS, 2019-2025
41 companies · $1,435 in 2025
The $1,435 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $528 · 2021: $922 · 2022: $1,116 · 2023: $1,309 · 2024: $1,108 · 2025: $1,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,851.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,590.18 | 2021-2025 | |
| Pfizer INC. | $768.60 | 2019-2025 | |
| Amgen INC. | $695.09 | 2019-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $626.05 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $521.39 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $364.08 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Biohaven Pharmaceutical Holding Company LTD. | $224.58 | 2022 | |
| Radius Health, INC. | $224.18 | 2019-2025 | Tymlos |
| Amarin Pharma, INC. | $186.08 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $170.85 | 2020-2025 | Airsupra, Evusheld |
| Exact Sciences Corporation | $164.36 | 2023-2025 | Cologuard Collection Kit |
| Stryker Corporation | $151.70 | 2020 | |
| Abbott Laboratories | $122.01 | 2022-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $85.91 | 2022-2023 | Belsomra, Steglatro, Verquvo |
| Eisai INC. | $70.65 | 2020-2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Lander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.